Two CTRND Researchers Ranked in the Top 20 of NIH Neuroscience Funding

Todd Golde, M.D., Ph.D. and Jada Lewis, Ph.D. have both been ranked in the top 20 for National Institutes of Health (NIH) funding in 2019 by the prestigious Blue Ridge Institute for Medical Research (BRIMR). The BRIMR annually provides a ranking of investigators and the total NIH funding received in support of their ongoing research. Both Dr. Golde and Dr. Lewis ranked in the top 20 of all researchers nationally, coming in at #6 and #19, respectively.

A professor in the Department of Neuroscience, Dr. Golde’s research focuses on the scientific understanding of Alzheimer’s disease where he is an internationally recognized expert. Additionally, he serves as Executive Director of the McKnight Brain Institute (MBI) and a member of the Norman Fixel Institute for Neurological Disease.

Dr. Lewis is a professor in the Department of Neuroscience where her research focuses on developing a refined understanding of the pathology of neurodegenerative disorders, including Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia and ALS. She also serves as Co-Deputy Director of the McKnight Brain Institute where she oversees the Education and Outreach Committee for the institute.

The Center for Translational Research in Neurodegenerative Disease (CTRND) is honored to count both of these researchers as members of the center and look forward to their continue success and breakthroughs in neurodegenerative disease research, congratulations!

To view the BRIMR 2019 rankings, please visit this link